L-Nutra, a Los Angeles, CA-based nutri-technology company, raised $47M in first tranche of its Series D funding.
The round is led by a personal investment from Mr. Stephane Bancel, CEO at Moderna Inc., alongside Brentwood Associates, a Los Angeles based middle market investment firm.
The company intends to use the funds to expand operations and its business reach.
Led by CEO Joseph Antoun, L-Nutra is a nutri-technology company which specializes in discovery, design and commercialization of novel nutrition for longevity and nutrition as medicine programs to enhance human healthspan. In partnership with 18 global university research centers, L-Nutra has developed the Nutrition for Longevity pipeline, ProLon® aimed at enhancing healthy aging via cellular rejuvenation and improving metabolic health; and Nutrition as Medicine pipeline called L-Nutra Health aimed at enhancing patients’ chances of remission from diabetes, cancer, autoimmune and cardiovascular diseases.
The company was founded in 2009 by The University of Southern California (USC) and Dr. Valter Longo, Director of the Longevity Institute at USC.
FinSMEs
08/11/2023